Novo Nordisk A S 20-F for FY2024
Novo Nordisk A S (NVO)
20-F
2025-02-05
For: 2024-12-31
View Original
Added on
April 09, 2026
About this 20-F
Novo Nordisk A S filed this 20-F on February 5, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 290.4B DKK
- up 25.0% from 232.26B DKK a year earlier
- Net income
- 100.99B DKK
- up 20.7% from net income of 83.68B DKK a year earlier
- Diluted EPS
- 22.63 DKK
- up 21.5% from 18.62 DKK a year earlier